Measurement of sulfidopeptide leukotrienes and their metabolism in human synovial fluid of patients with rheumatoid arthritis.
Leukotriene (LT)C4 in the synovial fluid of patients with osteoarthritis deformans (OA) and rheumatoid arthritis (RA) was measured by radioimmunoassay (RIA) after extraction with Sep-Pak C18 cartridge. The amounts of immunoreactive LTC4 (i-LTC4) in samples from patients with OA and RA were not significantly different, being 0.198 +/- 0.018 pmol/ml (n = 11) and 0.179 +/- 0.016 pmol/ml (n = 12), respectively. After separation by high performance liquid chromatography (HPLC) and measurement by RIA, the levels of other sulfidopeptide LTs, such as LTD4 and LTE4, in synovial fluid from patients with RA were found to be significantly higher than those in fluid from patients with OA. The leukocyte number in synovial fluids did not correlate with the i-LTC4 level. The metabolic activities of these synovial fluids were determined by incubating them with 3H-LTC4 and then separating sulfidopeptide LTs by HPLC. The conversion of LTC4 to LTD4 in synovial fluids of patients with OA and RA were similar, but the dipeptidase activity converting LTD4 to LTE4 was higher in fluid from patients with RA. It is suggested that a high level of LTE4 may contribute to exudation of synovial fluid, since LTE4 increases vascular permeability.
Koshihara
Y
Y
Department of Pharmacology, Tokyo Metropolitan Institute of Gerontology, Japan.
Isono
T
T
Oda
H
H
Karube
S
S
Hayashi
Y
Y
D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D017999:Leukotriene E4; D010003:Osteoarthritis / Q000378:metabolism; D013189:SRS-A / Q000031:analogs & derivatives* / Q000378:metabolism*; D013582:Synovial Fluid / Q000378:metabolism*
D013189:SRS-A; D017999:Leukotriene E4